These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 227598)
1. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598 [TBL] [Abstract][Full Text] [Related]
2. Experience of a German multicenter study group with ifosfamide in small cell lung cancer. Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648 [TBL] [Abstract][Full Text] [Related]
3. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213]. Joss R; Goldhirsch A; Cavalli F; Weber W; Kaplan S; Obrecht JP; Sonntag R; Brunner KW Schweiz Med Wochenschr; 1981 Sep; 111(36):1331-4. PubMed ID: 7197802 [TBL] [Abstract][Full Text] [Related]
5. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106 [TBL] [Abstract][Full Text] [Related]
6. [Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung]. Yokoyama A; Kinameri K; Kurita Y Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2573-8. PubMed ID: 6095762 [TBL] [Abstract][Full Text] [Related]
7. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer]. Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150 [TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers. Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma. Hainsworth JD; Stroup SL; Greco FA Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results. Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599 [TBL] [Abstract][Full Text] [Related]
12. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer. Bunn PA; Kelly K Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140 [TBL] [Abstract][Full Text] [Related]
13. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of advanced non-small cell lung cancer with the use of cis-platinum and VP 16-213. Villalon AH Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):641-5. PubMed ID: 3835710 [TBL] [Abstract][Full Text] [Related]
15. Intensive induction therapy for small cell carcinoma of the lung. Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117 [TBL] [Abstract][Full Text] [Related]
16. The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group. Banham S; Dorward A; Hutcheon A; Ahmedzai S; Cunningham D; Burnett A; Soukop M; Lucie N; Kaye S Semin Oncol; 1985 Mar; 12(1 Suppl 2):2-6. PubMed ID: 2983433 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer. Unsal M; Erturk D Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592 [TBL] [Abstract][Full Text] [Related]
18. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung]. Konno K; Nagahama F; Nakai Y; Nakabayashi T; Hiraga Y; Takebe K; Tamura M; Oizumi K; Sato M; Ito T Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671 [TBL] [Abstract][Full Text] [Related]
19. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
20. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]